GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
TAKAI, Toshiyuki. Roles of Fc receptors in autoimmunity. Nature Reviews Immunology. 2002-08, roč. 2, čís. 8, s. 580–592. Dostupné online [cit. 2022-06-21]. ISSN1474-1741. DOI10.1038/nri856. (anglicky)
Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD. Crystal structure of the extracellular domain of a human FcγRIII. Immunity. September 2000, s. 387–95. DOI10.1016/S1074-7613(00)00038-8. PMID11021536.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN2073-4468. DOI10.3390/antib2040617. (anglicky)
MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174
PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN1083-351X. DOI10.1074/jbc.M110.169516. PMID21123174.
GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867
PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN0021-9525. DOI10.1083/jcb.139.5.1209. PMID9382867.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292
PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.167.2.452. PMID2831292.
ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486
PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.182.3.801. PMID7650486.
VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN0028-3878. DOI10.1212/wnl.55.5.705. PMID10980740.
GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819
PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN1664-3224. DOI10.3389/fimmu.2016.00384. PMID27725819.
PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530
PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN1420-9071. DOI10.1007/s00018-013-1286-4. PMID23423530.
DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN1432-0851. DOI10.1007/s00262-012-1294-5. PMID22692756.
ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN1079-9796. DOI10.1006/bcmd.2002.0513. PMID12064921.
BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN1550-6606. DOI10.4049/jimmunol.181.6.4219. PMID18768879.
CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN1537-4513. DOI10.1097/CJI.0b013e31822801d4. PMID21760529.
JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419
PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN1533-3450. DOI10.1681/ASN.2019080847. PMID32165419.
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940
PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN1471-2172. DOI10.1186/s12865-020-00375-8. PMID32770940.
GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327
PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN1558-8238. DOI10.1172/JCI64837. PMID23006327.
SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558
PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN1091-6490. DOI10.1073/pnas.1819004116. PMID31076558.
SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN1474-1776. DOI10.1038/nrd1957. PMID16424916.
jimmunol.org
GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID8757624. (anglicky)
AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN2073-4468. DOI10.3390/antib2040617. (anglicky)
nature.com
TAKAI, Toshiyuki. Roles of Fc receptors in autoimmunity. Nature Reviews Immunology. 2002-08, roč. 2, čís. 8, s. 580–592. Dostupné online [cit. 2022-06-21]. ISSN1474-1741. DOI10.1038/nri856. (anglicky)
nih.gov
ncbi.nlm.nih.gov
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID1701792.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD. Crystal structure of the extracellular domain of a human FcγRIII. Immunity. September 2000, s. 387–95. DOI10.1016/S1074-7613(00)00038-8. PMID11021536.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID8757624. (anglicky)
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174
PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN1083-351X. DOI10.1074/jbc.M110.169516. PMID21123174.
GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867
PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN0021-9525. DOI10.1083/jcb.139.5.1209. PMID9382867.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292
PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.167.2.452. PMID2831292.
ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486
PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.182.3.801. PMID7650486.
VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN0028-3878. DOI10.1212/wnl.55.5.705. PMID10980740.
GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819
PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN1664-3224. DOI10.3389/fimmu.2016.00384. PMID27725819.
PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530
PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN1420-9071. DOI10.1007/s00018-013-1286-4. PMID23423530.
DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN1432-0851. DOI10.1007/s00262-012-1294-5. PMID22692756.
ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN1079-9796. DOI10.1006/bcmd.2002.0513. PMID12064921.
BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN1550-6606. DOI10.4049/jimmunol.181.6.4219. PMID18768879.
CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN1537-4513. DOI10.1097/CJI.0b013e31822801d4. PMID21760529.
JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419
PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN1533-3450. DOI10.1681/ASN.2019080847. PMID32165419.
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940
PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN1471-2172. DOI10.1186/s12865-020-00375-8. PMID32770940.
GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327
PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN1558-8238. DOI10.1172/JCI64837. PMID23006327.
SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558
PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN1091-6490. DOI10.1073/pnas.1819004116. PMID31076558.
SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN1474-1776. DOI10.1038/nrd1957. PMID16424916.
pubmed.ncbi.nlm.nih.gov
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID1701792.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174
PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN1083-351X. DOI10.1074/jbc.M110.169516. PMID21123174.
GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867
PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN0021-9525. DOI10.1083/jcb.139.5.1209. PMID9382867.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292
PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.167.2.452. PMID2831292.
ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486
PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.182.3.801. PMID7650486.
VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN0028-3878. DOI10.1212/wnl.55.5.705. PMID10980740.
GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819
PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN1664-3224. DOI10.3389/fimmu.2016.00384. PMID27725819.
PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530
PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN1420-9071. DOI10.1007/s00018-013-1286-4. PMID23423530.
DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN1432-0851. DOI10.1007/s00262-012-1294-5. PMID22692756.
ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN1079-9796. DOI10.1006/bcmd.2002.0513. PMID12064921.
BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN1550-6606. DOI10.4049/jimmunol.181.6.4219. PMID18768879.
CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN1537-4513. DOI10.1097/CJI.0b013e31822801d4. PMID21760529.
JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419
PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN1533-3450. DOI10.1681/ASN.2019080847. PMID32165419.
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940
PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN1471-2172. DOI10.1186/s12865-020-00375-8. PMID32770940.
GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327
PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN1558-8238. DOI10.1172/JCI64837. PMID23006327.
SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558
PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN1091-6490. DOI10.1073/pnas.1819004116. PMID31076558.
SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN1474-1776. DOI10.1038/nrd1957. PMID16424916.
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID1701792.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
TAKAI, Toshiyuki. Roles of Fc receptors in autoimmunity. Nature Reviews Immunology. 2002-08, roč. 2, čís. 8, s. 580–592. Dostupné online [cit. 2022-06-21]. ISSN1474-1741. DOI10.1038/nri856. (anglicky)
GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN0022-1767. PMID8757624. (anglicky)
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN2073-4468. DOI10.3390/antib2040617. (anglicky)
MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174
PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN1083-351X. DOI10.1074/jbc.M110.169516. PMID21123174.
GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867
PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN0021-9525. DOI10.1083/jcb.139.5.1209. PMID9382867.
MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937
PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN0027-8424. DOI10.1073/pnas.96.10.5640. PMID10318937.
ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292
PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.167.2.452. PMID2831292.
ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486
PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN0022-1007. DOI10.1084/jem.182.3.801. PMID7650486.
WAINSTEIN, E. The neutrophil FcγRIIIB is associated with renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum. 1996-04, roč. 39, čís. 4, s. 615–615. ISSN0004-3591.
VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN0028-3878. DOI10.1212/wnl.55.5.705. PMID10980740.
GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819
PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN1664-3224. DOI10.3389/fimmu.2016.00384. PMID27725819.
PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530
PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN1420-9071. DOI10.1007/s00018-013-1286-4. PMID23423530.
DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN1432-0851. DOI10.1007/s00262-012-1294-5. PMID22692756.
ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN1079-9796. DOI10.1006/bcmd.2002.0513. PMID12064921.
BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN1550-6606. DOI10.4049/jimmunol.181.6.4219. PMID18768879.
CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN1537-4513. DOI10.1097/CJI.0b013e31822801d4. PMID21760529.
JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419
PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN1533-3450. DOI10.1681/ASN.2019080847. PMID32165419.
GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429
PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN1097-4172. DOI10.1016/j.cell.2021.12.040. PMID35032429.
LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940
PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN1471-2172. DOI10.1186/s12865-020-00375-8. PMID32770940.
GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327
PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN1558-8238. DOI10.1172/JCI64837. PMID23006327.
SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558
PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN1091-6490. DOI10.1073/pnas.1819004116. PMID31076558.
SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN1474-1776. DOI10.1038/nrd1957. PMID16424916.